ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Avaya Holdings Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AVYA, AVYAW

NEW YORK, Jan. 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Avaya Holdings Corp. (NYSE: AVYA) (OTC: AVYAW) between November 22, 2021 and November 29, 2022, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 6, 2023.

SO WHAT: If you purchased Avaya securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Avaya class action, go to–form/?case_id=8033 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email or for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 6, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company's internal control over financial reporting (“ICFR”) was deficient in several areas; (2) as a result of these deficiencies, the Company had failed to design and maintain effective controls over its whistleblower policies and its ethics and compliance program; (3) the Company's deteriorating financial condition was likely to raise substantial doubt as to its ability to continue as a going concern; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Avaya class action, go to–form/?case_id=8033 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email or for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn:–rosen–law–firm, on Twitter: or on Facebook:

Attorney Advertising. Prior results do not guarantee a similar outcome.


Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827

GLOBENEWSWIRE (Distribution ID 8729172)

Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines

WASHINGTON, Jan. 12, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute today announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi–year contract with funding potential for up to $214 million to advance the development and production of single–dose vaccine candidates for Ebola Sudan and Marburg virus diseases.

There are currently no licensed vaccines against Ebola Sudan and Marburg viruses, which cause hemorrhagic fever and kill approximately half the people infected.

BARDA, part of the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response (ASPR), will initially invest approximately $35 million to produce up to 100,000 doses of Sabin's Ebola Sudan virus (ChAd3–SUDV) vaccine. These vaccines may be used as part of ongoing U.S. preparedness efforts and in response to future global outbreaks.

The Sabin vaccine was the first to arrive in Uganda during the recent Ebola Sudan virus outbreak that caused 55 deaths after the World Health Organization included it as one of three vaccines for possible use in an outbreak trial in Uganda. The country declared the Ebola Sudan outbreak had ended on January 11, four months after the first confirmed case.

"Sabin successfully delivered Ebola Sudan vaccine doses to Uganda within 79 days of the start of the outbreak "" quite an impressive accomplishment," says Sabin Chief Executive Officer Amy Finan. "This new contract enables Sabin to produce up to 100,000 doses so the world is prepared in advance for future outbreaks."

In addition to participating in recent outbreak activities, Sabin continues its Sudan development plan and has initiated Phase 2 clinical trial planning in Uganda and Kenya. Based on previous clinical trials, Sabin's Ebola Sudan vaccine is safe and immunogenic, and in nonhuman primate studies has demonstrated rapid protection, durability up to 12 months, and efficacy.

In addition to Sabin's ChAd3–SUDV vaccine, the contract also includes support to manufacture Sabin's vaccine against Marburg virus (ChAd3–MARV), which would generate doses that could also be used in trials and in response to a possible Marburg virus outbreak. As recently as last July, two people in Ghana died after being infected with Marburg virus, reinforcing the urgent need for a vaccine.

The new contract leverages a partnership with BARDA that began in 2019, when the agency awarded Sabin another multi–year contract valued at $128 million to further the development of vaccines against both the Marburg and Ebola Sudan viruses.

"BARDA has been a supportive partner as we take these essential steps in pandemic preparedness," said Finan. "The Ebola Sudan outbreak in Uganda underscored the critical need for readily available solutions. We'll now have ample material to respond quickly to such an outbreak in the future."

This project will be funded in whole with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number 75A50123C00010.

About the Sabin Vaccine Institute

The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non–profit with three decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit and follow us on Twitter, @SabinVaccine.

About Ebola Sudan and Marburg

Ebola Sudan and Marburg are members of the filovirus family. Both can cause severe hemorrhagic fever in humans and nonhuman primates. No therapeutic treatment of these hemorrhagic fevers has been licensed to date. Marburg and Ebola viruses are transmitted to humans by infected animals, particularly fruit bats. Once a human is infected, the virus can spread to others through close personal contact or contact with bodily fluids. Isolation of infected people is currently the centerpiece of filovirus control.

Marburg was the first filovirus to be recognized in 1967 when outbreaks of hemorrhagic fever were reported in a few Europe–based laboratories including in the town of Marburg, Germany. Ebola was identified in 1976 when two simultaneous outbreaks occurred in northern Zaire (now the DRC) in a village near the Ebola River and in southern Sudan. The outbreaks involved what eventually proved to be two different species of Ebola virus; both were named after the nations in which they were discovered.

For media inquiries:

Media Contact:
Monika Guttman
Media Relations Specialist
Sabin Vaccine Institute
+1 (202) 662–1841

A photo accompanying this announcement is available at–e5d6–4b32–9e89–780f7461314b

GLOBENEWSWIRE (Distribution ID 8728283)

Taking Humanitarianism Hostage – the Case of Afghanistan & Multilateral Organisations

Women receive food rations at a food distribution site in Herat, Afghanistan. Credit: UNICEF/Sayed Bidel

By Chloe Bryer, Azza Karam, Ruth Messinger and Negina Yari
NEW YORK, Jan 12 2023 – Can you imagine what it would be like if women were simply not allowed to step outside of their homes, let alone to work for a living? When women choose to do so, and they can afford it, then it is a matter of choice. When women mostly cannot, as is the case in Afghanistan now, not only is half the population imprisoned, but children go hungry, and communities sink deeper into poverty.

World Bank data (as incomplete as it is), indicates that the average number of female-headed households (i.e. households where women are the primary – if not the only – breadwinners), is around 25%.

What that means is, that on average, a quarter of all households around the world depend on women earning an income. Children, families, communities, and nations –depend on women’s work, to the tune of a quarter of their labour force.

Economists are still pointing to the obvious challenges of counting female labour, which often lies disproportionately on the frontiers of the formal economy, such that women continue to serve as reserve armies of labour and frontline workers during industrialization.

Economists who work to document these specificities, also point out that as soon as these frontiers expand or change, women are expelled or relegated to the shadows of the informal economy and piece-rate labour, identifying this as an all too frequent failure to recognize the importance of the kind of work many women engage in, which both keeps an economy running, and enables its expansion and growth.

The Covid-19 Pandemic should have resulted in a clear realisation that all hands are necessary on deck, with so many women actually needed as first responders–the backbone of the public health crisis – everywhere in the world.

As economies take a nosedive and the realities of recession hit many of us, all economies need to be kept running, if not to expand and grow.

And beyond these very real challenges to counting women’s work – and making that work count – there is another very critical reality: culture. Lest we think only of the vagaries of women who take over “men’s jobs” (whatever that means in today’s world), we need to stop being blind to the fact that women are needed to serve other women.

In fact, in many parts of the world, including the supposedly liberal and ‘egalitarian’ Western world, many women still prefer to receive life-saving direct services from other women – in public health, in sanitation, in all levels of education, in nutritional spaces, and many, many others.

Now let us pause a moment and consider humanitarian disaster zones, where women and girls often need to be cared for – and this can only be done by and through other women.

Then let us envision a reality one step further – let’s call it a socially conservative country, which is facing humanitarian disaster, and is heavily dependent on international organisations (governmental and non- governmental) for the necessary humanitarian support.

How is it conceivable that in such a context, women can be excluded from serving? And yet this is precisely what the Taliban have decreed on December 24, when it barred women from working in national and international NGOs. And this is after they banned women from higher education.

Many international NGOs halted their work in Afghanistan, explaining that they cannot work without their women staff – as a matter of principle, but also as a question of practical necessity. Yet, the United Nations – the premier multilateral entity – continues to see how they could compromise with the Taliban rule, for the sake of ‘the greater good – real humanitarian needs’.

Thank goodness they are letting the UN continue to work with their women employees, runs one way of thinking. We will not fail to deliver humanitarian needs, runs another UN way of thinking.

Of course, humanitarian needs are essential to human survival – and thus, should never be held hostage. But why is the United Nations being accountable for humanitarian needs only?

Meanwhile, the Taliban claim that these edicts about womens’ work and education are a matter of religious propriety, a claim which, as of this moment, is not strongly challenged by another multilateral entity – the Organisation of Islamic Cooperation (OIC), encompassing 56 governments and members of the United Nations.

While individual governments have spoken out, this multilateral entity has remained relatively silent on the Islamic justice of such a decree. Is it because this multilateral religious entity sees no need to speak to humanitarian needs?

Or is it because it sees no value to hard economic realities where women’s agency plays a central role? Or perhaps it is because there is no unanimity on the Islamic justification behind such decrees?

In light of this hostage-taking of humanitarian relief efforts, a group of women of faith leaders, have come together to ask some simple questions of the two multilateral entities involved. They have sent a letter with over 150 international NGO sign ons.

Multilateralism is supposed to be the guarantor of all human rights and dignity, for all people, at all times. But as governmental regimes weaken, so do traditional multilateral entities heavily reliant on those governments. Time for community based transnational networks based on intergenerational, multicultural, gender sensitive leaders.

Rev Dr Chloe Bryer is Executive Director, Interfaith Center of New York; Prof Azza Karam is Secretary General, Religions for Peace; Ruth Messinger is Social Justice Consultant, Jewish Theological Seminary; and Negina Yari is Country Director, Afghans4Tomorrow

IPS UN Bureau


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);;js.src=p+’://’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Indian PhD Students Say Long Australian Visa Delays Have Put Their Lives On Hold

Indian doctoral students are stuck due to Australian visa delays. Credit: Unsplash

Indian doctoral students are stuck due to Australian visa delays. Credit: Unsplash

By Neena Bhandari
Sydney, Jan 12 2023 – When Megha Jacob, who had been applying for a doctoral degree at various overseas universities, received an offer from the Australian National University’s Department of Chemistry to do a fully funded PhD, she was thrilled and immediately accepted the position.

It was January 2022. She submitted her visa application and resigned from her job at the Indian Institute of Technology Madras. One year later, she is still waiting for her visa to be processed.

Several international Indian students enrolled in doctoral degree courses in Australia’s leading universities have been waiting for their visas to be approved for months, some for up to two years. “The protracted delays have put our lives on hold. We seek clarity and a definitive timeline so we can plan our future,” say students from one of the WhatsApp groups formed by Indian doctoral students facing Australian visa processing delays.

Since the easing of Australia’s stringent COVID-19 restrictions, these students allege, the visa processing time for doctoral degree students has increased. “The median processing time for offshore student visa application was 18 days for the Postgraduate Research Sector in November 2022,” an Australian Department of Home Affairs (DHA) spokesperson tells IPS. However, the most recent processing time on the DHA website for 500 – Student visa (subclass 500) Postgraduate Research Sector shows 90 percent of applications are processed in 10 months.

Processing times will take some time to improve as the department works through older applications in the backlog, according to DHA. Processing times can vary due to applicants’ circumstances, including how long it takes to perform required checks on the supporting information provided by the applicant; and how long it takes to receive information from external agencies. This particularly relates to health, character and national security requirements.

Jacob says, “I have been submitting additional information, such as published research papers, but the last updated date on my visa application page on the DHA portal is still nine months old! I wonder if there is a technical glitch in the system or has my application fallen through the cracks.”

“When I called the DHA last month, I was told that waiting time for 90 percent of applicants is nine months [now its 10 months], and for the remaining 10 percent of applicants, we do not know how long it’s going to take. Presumably, some of us are in that 10 percent. But we don’t know why and what has placed our application in that category,” she adds.

Many students in the WhatsApp group have individually reached out to the DHA through email, the complaints section or via phone, but they have received only generic responses. “I have even written to the Commonwealth Ombudsman and received a similar reply that they are conducting necessary background checks, which can take several months,” says Deepak Chahal, who has a master’s from the Indian Institute of Space Science and Technology in Thiruvananthapuram (Kerala).

Chahal, who enrolled as a doctoral student in Macquarie University’s Department of Astronomy and Astrophysics in December 2020, has been waiting for the past two years for his visa to be processed. He says, “I had begun working remotely due to COVID-19 restrictions, but I can’t continue remotely anymore as I need access to Australian observatories to collect data and the lab to analyse it. I’ve already spent two years doing the research, so abandoning it now is not an option.”

For students in the field of applied science, technology and engineering, working remotely is not an option as they require access to a host of resources –laboratory, equipment, data, fast internet connectivity, and availability of supervisors to oversee their experiments.

“We are losing precious research time as we don’t even know if our visa application will be successful after all this waiting. Our lives are hanging in the balance,” says a 26-year-old applicant from Mumbai (Maharashtra), enrolled in The University of Sydney’s School of Chemistry, who requested anonymity. He applied for his visa in August 2022, as his date of joining was October 1. [Students can submit their application no later than six weeks before their course starts and no earlier than 12 weeks.] He has had to defer his research until his visa application is finalised.

Indian High Commissioner to Australia, Manpreet Vohra, tells IPS, “Many Indian doctorate students with admissions secured at various Australian universities have indeed been waiting for a very long time for their visas to be issued. This has delayed their research and, in some cases, has also jeopardised the grants that have been assured to them. We have been raising this matter regularly with Australian authorities and have urged them for early redressal of the difficulties that the doctorate students are facing.”

The DHA data shows that the higher education sector visa grant rate for 2022-2023 was 76.5 percent to November 30, 2022.

One beacon of hope, these students say, has been the support from Australian universities and the faculty. Dr Clement Canonne, Lecturer at the University of Sydney’s School of Computer Science, recently Tweeted on his personal account: “My hope for 2023 is not to have to raise the PhD and Postgraduate Research #AustralianVisas processing delays issue anymore, and to see not only the current backlog processed, but also increased transparency & communication from @ausgov for applicants.”

There were 1608 Indian nationals enrolled in Doctoral Degree courses out of the 96,005 Indian international students enrolled across all education sectors as of the year-to-date October 2022, according to a spokesperson for the Australian Government’s Department of Education. International students from India across all education sectors contributed $3.729 billion to the Australian economy in the 2021-22 financial year.

Speaking in his personal capacity and not expressing an official university viewpoint, Canonne tells IPS, “Students from India’s premier STEM institutes have many other options. When they, and Chinese and European students, choose to come to work with us, it’s because the research aligns. It’s really disheartening when these exceptional students are accepted, we work hard to apply for funding and get the grant, but then we can’t use the money to do the research for which it is meant because the students’ visa applications are pending for months, even years.”

The Department of Education data shows that in 2019, internationals accounted for 61 percent of Higher Degree Research students in engineering and related technologies and 57 percent in Information Technology.

“We chose Australia because it was a “perfect fit” when it came to the high ranking of Australian universities, professors in our field of research, lab facilities and other resources, full scholarship and shorter duration to complete a PhD in 3.5 years as against five years in most other countries,” says Parkarsh Kumar from Ranchi (Jharkhand), who is enrolled in UNSW Sydney’s Department of Material Science.

He says, “I completed my master’s degree from National Taiwan University on a scholarship and had two job offers, which I declined because I wanted to do a PhD and one day become a professor in an Indian institution. I was a role model in our family and community, but now everyone jokes that don’t be like him because I am sitting at home since January 2022 waiting for my visa application to be processed.”

Many of these students had left their jobs to pursue research, some against the wishes of their parents and elders. The long visa processing delays have caused them mental and financial stress. “If I apply for a job, I am asked why have I not worked for the past 10 months. If I say it’s because I am waiting for my Australian student visa, they immediately reject, stating that then there is no certainty on how long you will work for us,” says Jacob, who has socially isolated herself because while her family is very supportive, the societal pressure of being constantly asked, “When are you going to Australia?” is too much for her.

The long visa delay is prompting some to apply for a PhD in other countries or get a job. The Group of Eight (Go8), representing Australia’s leading research-intensive universities, in its submission dated December 16, 2022, to Australia’s 2023-24 Permanent Migration Program inquiry, noted that “visa backlogs are not just about the number of applicants in the queue, but about the critical expertise that Australia is missing out on, or stands to lose, because of avoidable processing delays.” It urged the DHA “to consider ways to improve and streamline visa assessment processes to facilitate migration in areas of priority or strategic need.”

IPS UN Bureau Report


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);;js.src=p+’://’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);